mounjaro and retatrutide Part 2 — continuing from where we left off., We finished on GIP how drugs like pushed results beyond GLP-1 alone., Now the conversation moves to — the next step people are The Truth About Weight Loss

Compounded semaglutide is considered an eligible medical expense when prescribed by a licensed provider for a diagnosed medical condition (obesity or type 2 diabetes)

What Phase 2 Research Reported About Weight Loss Published phase 2 research in adults with obesity or overweight reported dose-dependent weight loss

These are pragmatic, opinion-based observations rather than evidence-based recommendations, and neither approach has been shown to be clinically superior

More weight loss comes at a GI cost

It can signal healing, but it can also be present and harmful in the context of chronic disease

In addition to triggering insulin release, they also block the production of sugar, which helps lower blood sugar levels